BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 24830720)

  • 1. Genome-wide profiling of AP-1-regulated transcription provides insights into the invasiveness of triple-negative breast cancer.
    Zhao C; Qiao Y; Jonsson P; Wang J; Xu L; Rouhi P; Sinha I; Cao Y; Williams C; Dahlman-Wright K
    Cancer Res; 2014 Jul; 74(14):3983-94. PubMed ID: 24830720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AP-1 Is a Key Regulator of Proinflammatory Cytokine TNFα-mediated Triple-negative Breast Cancer Progression.
    Qiao Y; He H; Jonsson P; Sinha I; Zhao C; Dahlman-Wright K
    J Biol Chem; 2016 Mar; 291(10):5068-79. PubMed ID: 26792858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex.
    Soto U; Das BC; Lengert M; Finzer P; zur Hausen H; Rösl F
    Oncogene; 1999 May; 18(21):3187-98. PubMed ID: 10359524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AP-1-mediated chromatin looping regulates ZEB2 transcription: new insights into TNFα-induced epithelial-mesenchymal transition in triple-negative breast cancer.
    Qiao Y; Shiue CN; Zhu J; Zhuang T; Jonsson P; Wright AP; Zhao C; Dahlman-Wright K
    Oncotarget; 2015 Apr; 6(10):7804-14. PubMed ID: 25762639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AP-1 Transcription Factors c-FOS and c-JUN Mediate GnRH-Induced Cadherin-11 Expression and Trophoblast Cell Invasion.
    Peng B; Zhu H; Ma L; Wang YL; Klausen C; Leung PC
    Endocrinology; 2015 Jun; 156(6):2269-77. PubMed ID: 25794160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of activator protein-1 (AP-1) family members in breast cancer.
    Kharman-Biz A; Gao H; Ghiasvand R; Zhao C; Zendehdel K; Dahlman-Wright K
    BMC Cancer; 2013 Sep; 13():441. PubMed ID: 24073962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
    Suzukawa K; Colburn NH
    Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas.
    Milde-Langosch K; Röder H; Andritzky B; Aslan B; Hemminger G; Brinkmann A; Bamberger CM; Löning T; Bamberger AM
    Breast Cancer Res Treat; 2004 Jul; 86(2):139-52. PubMed ID: 15319566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
    Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.
    Chen B; Wang J; Dai D; Zhou Q; Guo X; Tian Z; Huang X; Yang L; Tang H; Xie X
    J Exp Clin Cancer Res; 2017 May; 36(1):65. PubMed ID: 28494797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cFos is critical for MCF-7 breast cancer cell growth.
    Lu C; Shen Q; DuPré E; Kim H; Hilsenbeck S; Brown PH
    Oncogene; 2005 Sep; 24(43):6516-24. PubMed ID: 16027729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells.
    Briggs J; Chamboredon S; Castellazzi M; Kerry JA; Bos TJ
    Oncogene; 2002 Oct; 21(46):7077-91. PubMed ID: 12370830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
    Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X
    Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells.
    Belguise K; Kersual N; Galtier F; Chalbos D
    Oncogene; 2005 Feb; 24(8):1434-44. PubMed ID: 15608675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells.
    Eriksson M; Taskinen M; Leppä S
    J Cell Physiol; 2007 Feb; 210(2):538-48. PubMed ID: 17111371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p75-Ras-GRF1 is a c-Jun/AP-1 target protein: its up regulation results in increased Ras activity and is necessary for c-Jun-induced nonadherent growth of Rat1a cells.
    Leaner VD; Donninger H; Ellis CA; Clark GJ; Birrer MJ
    Mol Cell Biol; 2005 Apr; 25(8):3324-37. PubMed ID: 15798216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
    Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A
    Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional regulation of Zic3 by heterodimeric AP-1(c-Jun/c-Fos) during Xenopus development.
    Lee SY; Lee HS; Moon JS; Kim JI; Park JB; Lee JY; Park MJ; Kim J
    Exp Mol Med; 2004 Oct; 36(5):468-75. PubMed ID: 15557819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion.
    Sundqvist A; Zieba A; Vasilaki E; Herrera Hidalgo C; Söderberg O; Koinuma D; Miyazono K; Heldin CH; Landegren U; Ten Dijke P; van Dam H
    Oncogene; 2013 Aug; 32(31):3606-15. PubMed ID: 22926518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.